ALGIPHARMA AS

Signals

1 flags

• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−6,9 mill kr).

ALGIPHARMA AS is registered as a limited company in Bærum, Akershus with organisation number 964911444. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 1992 and has 6 registered employees. Registered share capital is NOK 2.8m, divided into 11278404 shares. The company's stated purpose is: “Forskning og kommersialisering av forskningsprosjekter og forskningsresultater knyttet til alginater og annen bioteknologi og virksomhet i tilknytning til detter, herunder deltakelse i andre virksomheter gjennom aksjeeie eller på annen måte.”. The most recent filed accounts, for the 2024 financial year, show NOK 6,000 in revenue and NOK −6.9m in operating profit.

Key figures · 2024

Revenue

NOK 6,000

Operating profit

NOK −6.9m

Equity

NOK 176.1m

Est. value

NOK 286.2m

Financial health · 2024

Liquidity

0.35

Not satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

85.0%

Very good

Equity as a share of total capital

Who owns ALGIPHARMA AS?

ALGIPHARMA HOLDING AS

100.0%

ALGIPHARMA AS

NOK 6,000 rev. · NOK −6.9m profit

ALGIPHARMA AS has 1 registered shareholder:

• ALGIPHARMA HOLDING AS 100.0%

All shareholders and roles →

Frequently asked questions about ALGIPHARMA AS

Who owns ALGIPHARMA AS?

ALGIPHARMA HOLDING AS is the largest registered owner, with 100.0%.

What is the revenue of ALGIPHARMA AS?

ALGIPHARMA AS had revenue of NOK 6,000 in 2024.

Who is the general manager of ALGIPHARMA AS?

Yngvar Peter Berg is registered as general manager of ALGIPHARMA AS.

Where is ALGIPHARMA AS based?

ALGIPHARMA AS has its business address in Sandvika.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.